Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
- for the Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
Research output: Contribution to journal › Article › peer-review
4
Link opens in a new tab
Scopus
citations